| Acquirer | Target | Price |
|---|---|---|
| Astellas Pharma | Ocata Therapeutics | $379 million |
| Apollo Global Management | RegionalCare Hospital Partners | N/A |
| Virginia Mason Health System | Memorial Family of Services | Merger |
| Janssen Biotech | Rights to oxyntomodulin-based therapies | $105 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
